LexaGene (CVE:LXG) Shares Down 19.2%

LexaGene Holdings Inc. (CVE:LXGGet Free Report)’s share price was down 19.2% during trading on Tuesday . The stock traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares traded hands during trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.

LexaGene Stock Performance

The company has a 50 day moving average price of C$0.11 and a 200 day moving average price of C$0.11. The company has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26. The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39.

About LexaGene

(Get Free Report)

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.

Recommended Stories

Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.